Dr. Robert D. Kelly, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1500 Horizon Dr Ste 102b, Chalfont, PA 18914 Phone: 215-395-8888 Fax: 877-795-7518 |
Michael Joseph Mehnert, M.D. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Manor Dr, Chalfont, PA 18914 Phone: 800-321-9999 Fax: 267-479-1321 |
Christian Boris Acharte, Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Horizon Circle Ste 206, Chalfont, PA 18914 Phone: 215-395-8888 |
Dr. Edward Julius Rosero, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1200 Manor Dr, Chalfont, PA 18914 Phone: 267-339-3558 Fax: 267-339-3763 |
Dr. Huaguang Qu, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1500 Horizon Dr Ste 102b, Chalfont, PA 18914 Phone: 215-395-8888 Fax: 877-795-7518 |
News Archive
A new study from Drexel University College of Medicine suggests all organ transplant recipients, regardless of race, should receive routine, total-body screenings for skin cancer.
A new study provides an overview and comparison of the burden and management of fragility fractures due to osteoporosis in the five largest countries in Europe (France, Germany, Italy, Spain, and the United Kingdom) as well as Sweden.
Our genes control many aspects of who we are - from the colour of our hair to our vulnerability to certain diseases - but how are the genes, and consequently the proteins they make themselves controlled? Researchers have discovered a new group of molecules which control some of the fundamental processes behind memory function and may hold the key to developing new therapies for treating neurodegenerative diseases.
RegeneRx Biopharmaceuticals, Inc. reported that data showing that Thymosin beta 4 (Tβ4) "provides both neuroprotection and neurorestoration after traumatic brain injury (TBI)," was published in the current (May 2012) edition of the Journal of Neurosurgery, 116:1081-1092.
Avedro, Inc. announced today the completion of a $43 million Series D financing led by Abingworth along with a significant investment by Third Point.
› Verified 1 days ago